← All medicines
Dengue Tetravalent Vaccine (Live, Attenuated) Takeda
Licence EU/1/22/1699/001 · Unknown
- Licence holder
- Takeda GmbH (all products →)
- Active substances
- Dengue virus serotype 1# (live, attenuated), Dengue virus, serotype 2, live, attenuated, Dengue virus serotype 3# (live, attenuated), Dengue virus serotype 4# (live, attenuated)
- Dosage form
- Powder and solvent for solution for injection
- Route of administration
- Subcutaneous use
- ATC code
- J07BX04
- First authorised
- 05/12/2022
- Prescription status
- Product subject to prescription which may not be renewed (A)
- Supply
- Supply through pharmacies only
- Legal basis
- Full application (Article 8(3) of Directive No 2001/83/EC)
Data: Health Products Regulatory Authority (HPRA) open dataset, licensed CC BY 4.0, published 04 Jul 2026. This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.